situation and will be utmost benefit for the company in the future. However, IFA has an observation that AM?s service fee should be based on operating profit or net profit, and it should not be charged if GJS
able to continuously generate cash sales in each branch. 3. Analysis of Operating Results Profit & Loss Statements (MB) for the Quarter 1 Ending 31 Mar +/(-) % 2019 2018 Revenues from sales and services
11.67 0.56 6.05 Total cost of sales 54.04 100.00 84.21 100.00 30.17 55.83 Proportion of cost of sales to sales revenue (%) 26.72 44.27 Gross Profit Margin (%) 73.28 55.73 Note: /1 Other costs of goods
with total revenue from medical treatment for the 1st quarter of Year 2019, equaled to 78.4% comparing to the 1st quarter of Year 2018, equaled to 63.3%. There are two main reasons of the increasing in
Discussion & Analysis Q3/2021 Operating Highlights in Q3/2021 Q3/20 Q3/21 Change +/(-) 9M/20 9M/21 Change +/(-) (THB million) %YoY %YoY Operating Revenue 198 115 (42%) 561 431 (23%) Gross Profit 124 60 (52
Summary Significant Events Operating Highlights in Q1/2023 Q1/22 Q1/23 Change +/(-) (THB million) %YoY Operating Revenue 198 264 33% Gross Profit 120 168 40% EBITDA 58 80 38% Net Profit (Loss) for the
507.9 1,179.2 671.3 132.2 Project Management and overhead expenses 158.5 273.3 114.8 72.4 Total Expenses 2,390.6 7,114.9 4,724.3 197.6 Profit before share of loss from investments in joint ventures, 808.5
period -15.79 -50.76 34.97 68.89 Non-controlling interests of the subsidiaries 0.06 0.00 0.06 Profit(Loss) attributable to equity holders of the company -15.55 -50.62 35.07 69.28 Basic Loss Per Share (Baht
received from current investment. 2. Cost of sale , Profit margin In Q2/2017 the company had cost of sale Baht 82.97 million compare with the same period of previous year amount to Baht 68.01 million
recorded income incurred from deferred tax for the amount of THB 28.6 million. The net amount after amortization was 27.6 million in the first 6-month period of 2017 Operation : Consolidated Profit & Loss